| News for nurse practitioners
|  |
- Vitamin D supplementation doesn't ward off colds in study
Monthly doses of vitamin D supplements did not significantly reduce the incidence of colds and other respiratory infections, a New Zealand study found. No difference was seen in disease severity and the duration of colds between the vitamin D group and a placebo group. The findings appear in the Journal of the American Medical Association. Reuters
(10/2)      
- Rheumatoid arthritis raises risk of blood clots, study finds
A Swedish study found that people with rheumatoid arthritis have a higher risk of developing blood clots in their veins in the 10 years after diagnosis than people without the condition. The risk increases when patients are hospitalized. The findings appeared in the Journal of the American Medical Association. HealthDay News
(10/2)
- Cherries may reduce risk of gout flares
 Researchers followed 633 people with gout for one year and found that eating cherries for two days was associated with a 35% reduction in risk of gout attacks. Combining cherry intake with allopurinol, a uric acid-lowering drug, was linked to a 75% reduction. The study appeared in the journal Arthritis & Rheumatism. Medical News Today
(9/30)
- Low eGFR increases CAD risk in type 1 diabetes
Among type 1 diabetes patients with good glucose control, those who had lower estimated glomerular filtration rate faced a greater risk of coronary artery disease than patients with higher eGFR, a study presented at the European Association for the Study of Diabetes meeting showed. Researchers said hypertension may also predict CAD risk in patients with both high and low HbA1C levels. MedPage Today (free registration)
(10/2)
|
|
 | Inform and Empower
Take action TODAY with a pain advocacy resource that provides inspiration, pain related
news, downloadable materials and tools to inform and empower people
with pain, health care professionals, caregivers and other concerned individuals.
Visit www.IntheFaceofPain.com and download the Handbook for People with
Pain: a Resource Guide, 3rd edition , a resource to help you or a loved on the day-to-day journey facing challenges so often encountered by those who suffer with
pain. |
|
|
| Pharmaceutical News |  |  |
|
- Fewer nocturnal hypoglycemic episodes seen with insulin degludec
Type 2 diabetes patients who took insulin degludec or insulin glargine attained similar mean HbA1C and fasting plasma glucose levels at 52 weeks, a study found. However, fewer nocturnal hypoglycemic episodes were seen in the degludec-treated patients at one year, compared with those who took glargine. The results were presented at the European Association for the Study of Diabetes meeting. InternalMedicineNews.com
(10/2)
- Study: Tesamorelin boosts metabolic markers in obese
Centrally obese patients with lower growth hormone secretion who received tesamorelin treatment attained better lean body mass, waist circumference and visceral adipose tissue levels compared with the control group, a study in The Journal of Clinical Endocrinology and Metabolism indicated. Researchers also found tesamorelin was associated with a 90% increase in insulin-like growth factor I, a 20% decrease in triglyceride rates and a 24% reduction in C-reactive protein levels. Healio/Endocrine Today
(10/2)
| Emerging Trends, Products and Technologies | | |
|
- More than 15 million Americans are severely obese, data show
About 6.6%, or 15.5 million, U.S. adults were severely obese in 2010, compared with 3.9% in 2000, according to RAND Corp. data published in the International Journal of Obesity. Data showed the rate of severe obesity -- which is a BMI of 40 or higher or roughly being 100 pounds or more over a healthy weight -- was 50% higher in women than in men and twice as high for blacks as for Hispanics and whites. USA TODAY
(10/1)
- Study backs EHR's efficacy in diabetes management
A study in the Annals of Internal Medicine found outpatient EHR system adoption was associated with greater treatment intensification in diabetes patients with higher HbA1c percentages. EHR use was also linked to a higher likelihood of follow-up testing within a year as well as fewer HbA1c retests within 90 days for patients whose blood sugar was under control. Medscape (free registration)
(10/1)
| Health Policy and Legislative News | | |
|
| AANP News | | |
|
-
HHS awards new round of grants
HHS has awarded a new round of Affordable Insurance Exchange Establishment Grants to Arkansas, Colorado, Kentucky, Massachusetts, Minnesota and the District of Columbia to create new health insurance marketplaces, known as exchanges. Under the Affordable Care Act, consumers and small businesses will have access starting in 2014 to one-stop marketplaces for quality, affordable private health insurance choices similar to those offered to members of Congress, and consumers may be eligible for tax credits to help pay for their health insurance. A total of 49 states, the District of Columbia, and four territories have received grants for planning, and 34 states and the District of Columbia have received grants to begin building exchanges. States may apply for grants through the end of 2014 and may use funds through the initial startup year. Learn more and find a detailed breakdown of exchange grants.
-
JAANP October issue is now available online
Read new research on women's experiences before, during and after a diagnosis of ovarian cancer. AANP members have full access to all articles by logging on to the members-only area of www.aanp.org.
| SmartQuote | | |
|
 | There is nothing so agonizing to the fine skin of vanity as the application of a rough truth."
--Edward Bulwer-Lytton,
British politician, poet, playwright and novelist
|
| |
| Advertise |
| Account Director:
Aaron Kern (202) 407-7866
|
|
|
| |
|
Read more at SmartBrief.com |
|
A powerful website for SmartBrief readers including:
|
|
|
|
| |
| |
| | Recent AANP SmartBrief Issues:
- Tuesday, October 02, 2012
- Monday, October 01, 2012
- Friday, September 28, 2012
- Thursday, September 27, 2012
- Wednesday, September 26, 2012
| | | Lead Editor: Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | |
| |
|
| © 1999-2012 SmartBrief, Inc.® Legal Information |
|
